Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph I Clark

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Medical Oncology (Northwood, London, England)|December 26, 2012
Phase I pilot study of oxaliplatin, infusional 5-FU, and cetuximab in recurrent or metastatic head and neck cancerJoseph I Clark, Joshua B Greene, Ann Lau Clark, et al.
Case Reports in Oncological Medicine|October 28, 2015
Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the FaceAlec M Block, Fiori Alite, Aidnag Z Diaz, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 29, 2015
Robust Differences in p16-Dependent Oropharyngeal Squamous Cell Carcinoma Distant Metastasis: Implications for Targeted TherapyJames J Jaber, Lauren Murrill, Joseph I Clark, et al.
Archives of Pathology & Laboratory Medicine|October 27, 2004
Renal tumor with overlapping distal nephron morphology and karyotypeValerie Lindgren, Gladell P Paner, Robert C Flanigan, et al.
NDT Plus|May 19, 2015
Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutationSeth A Levey, Randeep S Bajwa, Maria M Picken, et al.
Head & Neck|October 30, 2013
Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329Binu Malhotra, James Moon, Omar Kucuk, et al.
Cancer|October 13, 2007
Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026Laura F Hutchins, James Moon, Joseph I Clark, et al.
Head & Neck|September 18, 2010
Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experienceJames J Jaber, Joseph I Clark, Kamil Muzaffar, et al.
World Journal of Surgical Oncology|January 3, 2025
A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanomaJ Michael Guenther, Andrew Ward, Brian J Martin, et al.
Clinical Genitourinary Cancer|May 27, 2008
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancerRichard T Lee, Kathleen E Beekman, Maha Hussain, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Medical Oncology (Northwood, London, England)|December 26, 2012
Phase I pilot study of oxaliplatin, infusional 5-FU, and cetuximab in recurrent or metastatic head and neck cancerJoseph I Clark, Joshua B Greene, Ann Lau Clark, et al.
Case Reports in Oncological Medicine|October 28, 2015
Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the FaceAlec M Block, Fiori Alite, Aidnag Z Diaz, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 29, 2015
Robust Differences in p16-Dependent Oropharyngeal Squamous Cell Carcinoma Distant Metastasis: Implications for Targeted TherapyJames J Jaber, Lauren Murrill, Joseph I Clark, et al.
Archives of Pathology & Laboratory Medicine|October 27, 2004
Renal tumor with overlapping distal nephron morphology and karyotypeValerie Lindgren, Gladell P Paner, Robert C Flanigan, et al.
NDT Plus|May 19, 2015
Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutationSeth A Levey, Randeep S Bajwa, Maria M Picken, et al.
Head & Neck|October 30, 2013
Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329Binu Malhotra, James Moon, Omar Kucuk, et al.
Cancer|October 13, 2007
Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026Laura F Hutchins, James Moon, Joseph I Clark, et al.
Head & Neck|September 18, 2010
Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experienceJames J Jaber, Joseph I Clark, Kamil Muzaffar, et al.
World Journal of Surgical Oncology|January 3, 2025
A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanomaJ Michael Guenther, Andrew Ward, Brian J Martin, et al.
Clinical Genitourinary Cancer|May 27, 2008
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancerRichard T Lee, Kathleen E Beekman, Maha Hussain, et al.
Pageof 7